✦ LIBER ✦

Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms

✍ Scribed by Marta Fernández-Mercado; Virginia Cebrián; Begoña Euba; Marta García-Granero; María J. Calasanz; Francisco J. Novo; José L. Vizmanos; Marina García-Delgado

Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 73 KB
Volume: 32
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2008.03.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simultaneous occurrence of the JAK2V617F

Simultaneous occurrence of the JAK2V617F mutation and BCR-ABL gene rearrangement in patients with chronic myeloproliferative disorders

✍ Yeo-Kyeoung Kim; Myung-Geun Shin; Hye-Ran Kim; Deok-Hwan Yang; Sang-Hee Cho; Je- 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Genetic analysis of chromosome 13 deleti

Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders

✍ Cristina Pastore; Josep Nomdedeu; Gisella Volpe; Angelo Guerrasio; Giovanna Rege 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

## Abstract Chromosomal deletions of band 13q14 occur recurrently in __BCR/ABL__ negative chronic myeloproliferative disorders (CMPD), including myelosclerosis with myeloid metaplasia (MMM), polycythemia vera (PV), essential thrombocythemia (ET), juvenile chronic myeloid leukemia (JCML), and the so

Chronic myeloid leukemia 2011: Successes

Chronic myeloid leukemia 2011: Successes, challenges, and strategies—Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop

✍ Tariq I. Mughal; Jerald P. Radich; Richard A. Van Etten; Alfonso Quintás-Cardama 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

PEG-IFN-α-2b therapy in BCR-ABL–negative

PEG-IFN-α-2b therapy in BCR-ABL–negative myeloproliferative disorders : Final Result of a Phase 2 Study

✍ Elias Jabbour; Hagop Kantarjian; Jorge Cortes; Deborah Thomas; Guillermo Garcia- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract ## BACKGROUND. Interferon‐alpha (IFN‐α) has shown significant activity in the treatment of BCR‐ABL–negative myeloproliferative disorders (MPDs), particularly essential thrombocythemia (ET) and polycythemia vera (PV). PEG‐IFN‐α‐2b is a pegylated IFN‐α‐2b with a significant advantage ove

Hyperfunction of neutrophils in a patien

Hyperfunction of neutrophils in a patient with BCR/ABL negative chronic myeloid leukemia : A case report with in vitro studies

✍ Kiyoshi Watari; Arinobu Tojo; Tokiko Nagamura-Inoue; Masaaki Matsuoka; Seiji Iri 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 3 views

Generation of the BCR/ABL fusion gene in

Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22

✍ Laura Valle; Victoria Fernández; Concepción Pérez-Pons; Félix García Sánchez; Ja 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

## Abstract This report describes a chronic myelogenous leukaemia patient with an apparently normal bone marrow karyotype but __BCR/ABL__ fusion‐gene‐positive. Commercial FISH probes showed an atypical pattern and the __BCR/ABL__ fusion transcript was detected by RT‐PCR, but not the reciprocal __AB